tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Revenue

Compare
380 Followers

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had a revenue of 2.78M in the quarter ending Dec 31, 2025, with -78.22%. This bring the company's revenue in the last twelve months to 123.67M, Increased -31.88%. In the fiscal year ending Dec 31, 2025, Monte Rosa Therapeutics had annual revenue of 123.67M with 63.54% growth.
Revenue (ttm)
123.67M
Revenue Growth
1112.27%
P/S Ratio
9.88
Revenue/Employee
$870,930
Employees
142
Market Cap
$1.22B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
123.67M48.05M+63.54%
Dec 31, 2024
75.62M+∞%
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019